Intravenous, Oral, and the Combination of Intravenous and Oral Ramosetron for the Prevention of Nausea and Vomiting After Laparoscopic Cholecystectomy: A Randomized, Double-Blind, Controlled Trial

Clinical Therapeutics

Volumn 33, Issue 9, 2011, Pages 1162-1172

  Ryu, Jung Hee ^a   Jeon, Young Tae ^a   Hwang, Jung Won ^a   Oh, A Young ^a   Moon, Ji Yeon ^b   Ro, Young Jin ^c   Kim, Chong Soo ^d   Chen, Chen ^e   Apfel, Christian C ^e   Do, Sang Hwan ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Asan Medical Center   (South Korea)

^d Seoul National University Boramae Hospital   (South Korea)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Laparoscopic cholecystectomy; PONV; Ramosetron

Indexed keywords

DESFLURANE; METOCLOPRAMIDE; ONDANSETRON; RAMOSETRON; REMIFENTANIL;

ADULT; AGED; ARTICLE; CHOLECYSTECTOMY; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PERIOD; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; RETCHING; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIEMETICS; BENZIMIDAZOLES; CHOLECYSTECTOMY, LAPAROSCOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; POSTOPERATIVE NAUSEA AND VOMITING; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80052980274     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.07.018     Document Type: Article

References (47)

1. Fujii Y. The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy. Curr Pharm Des 2005, 11:3173-3183.
2. Parris W.C., Lee E.M. Anaesthesia for laparoscopic cholecystectomy. Anaesthesia 1991, 46:997.
3. Thune A., Appelgren L., Haglind E. Prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. A prospective randomized study of metoclopramide and transdermal hyoscine. Eur J Surg 1995, 161:265-268.
4. Sohi H.S., Heipel J., Inman K.J., et al. Preoperative transdermal scopolamine does not reduce the level of nausea and frequency of vomiting after laparoscopic cholecystectomy. Can J Surg 1994, 37:307-312.
5. Kothari S.N., Boyd W.C., Bottcher M.L., Lambert P.J. Antiemetic efficacy of prophylactic dimenhydrinate (Dramamine) vs ondansetron (Zofran): a randomized, prospective trial in patients undergoing laparoscopic cholecystectomy. Surg Endosc 2000, 14:926-929.
6. Parlow J.L., Meikle A.T., van Vlymen J., Avery N. Post discharge nausea and vomiting after ambulatory laparoscopy is not reduced by promethazine prophylaxis. Can J Anaesth 1999, 46:719-724.
7. Fujii Y., Tanaka H., Toyooka H. Prophylactic antiemetic therapy with droperidol in patients undergoing laparoscopic cholecystectomy. J Anesth 1999, 13:140-143.
8. Nesek-Adam V., Grizelj-Stojcic E., Rasic Z., et al. Comparison of dexamethasone, metoclopramide, and their combination in the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Surg Endosc 2007, 21:607-612.
9. Leksowski K., Peryga P., Szyca R. Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study. Surg Endosc 2006, 20:878-882.
10. Paventi S., Santevecchi A., Ranieri R. Efficacy of a single-dose ondansetron for preventing post-operative nausea and vomiting after laparoscopic cholecystectomy with sevoflurane and remifentanil infusion anaesthesia. Eur Rev Med Pharmacol Sci 2001, 5:59-63.
11. Quaynor H., Raeder J.C. Incidence and severity of postoperative nausea and vomiting are similar after metoclopramide 20 mg and ondansetron 8 mg given by the end of laparoscopic cholecystectomies. Acta Anaesthesiol Scand 2002, 46:109-113.
12. Fujii Y., Uemura A., Tanaka H. Prophylaxis of nausea and vomiting after laparoscopic cholecystectomy with ramosetron: randomised controlled trial. Eur J Surg 2002, 168:583-586.
13. Biswas B.N., Rudra A. Comparison of granisetron and granisetron plus dexamethasone for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Acta Anaesthesiol Scand 2003, 47:79-83.
14. Gan T.J. Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?. CNS Drugs 2005, 19:225-238.
15. Rabasseda X. Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting. Drugs Today (Barc) 2002, 38:75-89.
16. Shi Y., He X., Yang S., et al. Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: a prospective randomized controlled study. Chemotherapy 2007, 53:44-50.
17. Kang Y.K., Park Y.H., Ryoo B.Y., et al. Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron. J Int Med Res 2002, 30:220-229.
18. Fujii Y., Tanaka H. Comparison of granisetron and ramosetron for the prevention of nausea and vomiting after thyroidectomy. Clin Ther 2002, 24:766-772.
19. Fujii Y., Tanaka H. Double-blind, placebo-controlled, dose-ranging study of ramosetron for the prevention of nausea and vomiting after thyroidectomy. Clin Ther 2002, 24:1148-1153.
20. Ryu J., So Y.M., Hwang J., Do S.H. Ramosetron versus ondansetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Surg Endosc 2010, 24:812-817.
21. Fujii Y., Saitoh Y., Tanaka H., Toyooka H. Ramosetron vs granisetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Can J Anaesth 1999, 46:991-993.
22. Gan T.J., Meyer T.A., Apfel C.C., et al. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007, 105:1615-1628.
23. Coloma M., White P.F., Markowitz S.D., et al. Dexamethasone in combination with dolasetron for prophylaxis in the ambulatory setting: effect on outcome after laparoscopic cholecystectomy. Anesthesiology 2002, 96:1346-1350.
24. Grover V.K., Mathew P.J., Hegde H. Efficacy of orally disintegrating ondansetron in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomised, double-blind placebo controlled study. Anaesthesia 2009, 64:595-600.
25. Watcha M.F., White P.F. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992, 77:162-184.
26. Navari R.M., Koeller J.M. Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists. Ann Pharmacother 2003, 37:1276-1286.
27. Apfel C.C., Roewer N., Korttila K. How to study postoperative nausea and vomiting. Acta Anaesthesiol Scand 2002, 46:921-928.
28. Apfel C.C., Laara E., Koivuranta M., et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999, 91:693-700.
29. Gan T.J. Risk factors for postoperative nausea and vomiting. Anesth Analg 2006, 102:1884-1898.
30. Koivusalo A.M., Kellokumpu I., Lindgren L. Postoperative drowsiness and emetic sequelae correlate to total amount of carbon dioxide used during laparoscopic cholecystectomy. Surg Endosc 1997, 11:42-44.
31. Caldwell C.B., Ricotta J.J. Changes in visceral blood flow with elevated intraabdominal pressure. J Surg Res 1987, 43:14-20.
32. Diebel L.N., Dulchavsky S.A., Wilson R.F. Effect of increased intra-abdominal pressure on mesenteric arterial and intestinal mucosal blood flow. J Trauma 1992, 33:45-48.
33. Lee H.J., Kwon J.Y., Shin S.W., et al. Preoperatively administered ramosetron oral disintegrating tablets for preventing nausea and vomiting associated with patient-controlled analgesia in breast cancer patients. Eur J Anaesthesiol 2008, 25:756-762.
34. Lee D., Kim J.Y., Shin J.W., et al. The effect of oral and IV ramosetron on postoperative nausea and vomiting in patients undergoing gynecological laparoscopy with total intravenous anesthesia. J Anesth 2009, 23:46-50.
35. Yano S., Makino K., Nakamura H., et al. Comparative clinical study of the anti-emetic effects of oral ramosetron and injected granisetron in patients with malignant glioma undergoing ACNU chemotherapy. Neurol Med Chir (Tokyo) 2005, 45:294-298.
36. Umenai T., Arai N., Chihara E. Effect of the preliminary hydration on gastric emptying time for water in healthy volunteers. Acta Anaesthesiol Scand 2009, 53:223-226.
37. Diemunsch P., Joshi G.P., Brichant J.F. Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting. Br J Anaesth 2009, 103:7-13.
38. Gershon M.D. Review article: serotonin receptors and transporters-roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004, 20(Suppl 7):3-14.
39. Koga T., Fukuda H. Neurons in the nucleus of the solitary tract mediating inputs from emetic vagal afferents and the area postrema to the pattern generator for the emetic act in dogs. Neurosci Res 1992, 14:166-179.
40. Hesketh P.J. Chemotherapy-induced nausea and vomiting. N Engl J Med 2008, 358:2482-2494.
41. Rosow C.E. An overview of remifentanil. Anesth Analg 1999, 89(4 Suppl):S1-S3.
42. Song D., White P.F. Remifentanil as an adjuvant during desflurane anesthesia facilitates early recovery after ambulatory surgery. J Clin Anesth 1999, 11:364-367.
43. Mraovic B., Simurina T., Sonicki Z., et al. The dose-response of nitrous oxide in postoperative nausea in patients undergoing gynecologic laparoscopic surgery: a preliminary study. Anesth Analg 2008, 107:818-823.
44. Myles P.S., Leslie K., Chan M.T., et al. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology 2007, 107:221-231.
45. Olsen J.C., McGrath N.A., Schwarz D.G., et al. A double-blind randomized clinical trial evaluating the analgesic efficacy of ketorolac versus butorphanol for patients with suspected biliary colic in the emergency department. Acad Emerg Med 2008, 15:718-722.
46. Jackson C.W., Sheehan A.H., Reddan J.G. Evidence-based review of the black-box warning for droperidol. Am J Health Syst Pharm 2007, 64:1174-1186.
47. Apfel C.C., Zhang K., George E., et al. Transdermal scopolamine for the prevention of postoperative nausea and vomiting: a systematic review and meta-analysis. Clin Ther 2010, 32:1987-2002.